• Something wrong with this record ?

t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma

A. Caliò, M. Brunelli, D. Segala, S. Pedron, R. Tardanico, A. Remo, S. Gobbo, E. Meneghelli, C. Doglioni, O. Hes, C. Zampini, P. Argani, G. Martignoni,

. 2018 ; 31 (3) : 474-487. [pub] 20171020

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc19028714

Renal cell carcinomas with t(6;11) chromosome translocation involving the TFEB gene are indolent neoplasms which often occur in young patients. In this study, we report seven cases of renal cell carcinoma with TFEB rearrangement, two of whom had histologically proven metastasis. Patients (4F, 3M) ranged in age from 19 to 55 years (mean 37). One patient developed paratracheal and pleural metastases 24 months after surgery and died of disease after 46 months; another one recurred with neoplastic nodules in the perinephric fat and pelvic soft tissue. Histologically, either cytological or architectural appearance was peculiar in each case whereas one tumor displayed the typical biphasic morphology. By immunohistochemistry, all tumors labelled for cathepsin K, Melan-A and CD68 (KP1 clone). HMB45 and PAX8 staining were detected in six of seven tumors. All tumors were negative for CD68 (PG-M1 clone), CKAE1-AE3, CK7, CAIX, and AMACR. Seven pure epithelioid PEComa/epithelioid angiomyolipomas, used as control, were positive for cathepsin K, melanocytic markers, and CD68 (PG-M1 and KP1) and negative for PAX8. Fluorescence in situ hybridization results showed the presence of TFEB gene translocation in all t(6;11) renal cell carcinomas with a high frequency of split TFEB fluorescent signals (mean 74%). In the primary and metastatic samples of the two aggressive tumors, increased gene copy number was observed (3-5 fluorescent signals per neoplastic nuclei) with a concomitant increased number of CEP6. Review of the literature revealed older age and larger tumor size as correlating with aggressive behavior in these neoplasms. In conclusion, we present the clinical, morphological and molecular features of seven t(6;11) renal cell carcinomas, two with histologically demonstrated metastasis. We report the high frequency of split signals by FISH in tumors with t(6;11) chromosomal rearrangement and the occurrence of TFEB gene copy number gains in the aggressive cases, analyzing either the primary or metastatic tumor. Finally, we demonstrate the usefulness of CD68 (PG-M1) immunohistochemical staining in distinguishing t(6;11) renal cell carcinoma from pure epithelioid PEComa/epithelioid angiomyolipoma.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19028714
003      
CZ-PrNML
005      
20190823102352.0
007      
ta
008      
190813s2018 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1038/modpathol.2017.144 $2 doi
035    __
$a (PubMed)29052596
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Caliò, Anna $u Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy.
245    10
$a t(6;11) renal cell carcinoma: a study of seven cases including two with aggressive behavior, and utility of CD68 (PG-M1) in the differential diagnosis with pure epithelioid PEComa/epithelioid angiomyolipoma / $c A. Caliò, M. Brunelli, D. Segala, S. Pedron, R. Tardanico, A. Remo, S. Gobbo, E. Meneghelli, C. Doglioni, O. Hes, C. Zampini, P. Argani, G. Martignoni,
520    9_
$a Renal cell carcinomas with t(6;11) chromosome translocation involving the TFEB gene are indolent neoplasms which often occur in young patients. In this study, we report seven cases of renal cell carcinoma with TFEB rearrangement, two of whom had histologically proven metastasis. Patients (4F, 3M) ranged in age from 19 to 55 years (mean 37). One patient developed paratracheal and pleural metastases 24 months after surgery and died of disease after 46 months; another one recurred with neoplastic nodules in the perinephric fat and pelvic soft tissue. Histologically, either cytological or architectural appearance was peculiar in each case whereas one tumor displayed the typical biphasic morphology. By immunohistochemistry, all tumors labelled for cathepsin K, Melan-A and CD68 (KP1 clone). HMB45 and PAX8 staining were detected in six of seven tumors. All tumors were negative for CD68 (PG-M1 clone), CKAE1-AE3, CK7, CAIX, and AMACR. Seven pure epithelioid PEComa/epithelioid angiomyolipomas, used as control, were positive for cathepsin K, melanocytic markers, and CD68 (PG-M1 and KP1) and negative for PAX8. Fluorescence in situ hybridization results showed the presence of TFEB gene translocation in all t(6;11) renal cell carcinomas with a high frequency of split TFEB fluorescent signals (mean 74%). In the primary and metastatic samples of the two aggressive tumors, increased gene copy number was observed (3-5 fluorescent signals per neoplastic nuclei) with a concomitant increased number of CEP6. Review of the literature revealed older age and larger tumor size as correlating with aggressive behavior in these neoplasms. In conclusion, we present the clinical, morphological and molecular features of seven t(6;11) renal cell carcinomas, two with histologically demonstrated metastasis. We report the high frequency of split signals by FISH in tumors with t(6;11) chromosomal rearrangement and the occurrence of TFEB gene copy number gains in the aggressive cases, analyzing either the primary or metastatic tumor. Finally, we demonstrate the usefulness of CD68 (PG-M1) immunohistochemical staining in distinguishing t(6;11) renal cell carcinoma from pure epithelioid PEComa/epithelioid angiomyolipoma.
650    _2
$a dospělí $7 D000328
650    _2
$a angiomyolipom $x chemie $x patologie $7 D018207
650    _2
$a CD antigeny $x analýza $7 D015703
650    _2
$a antigeny diferenciační myelomonocytární $x analýza $7 D015214
650    _2
$a transkripční faktory BHLH-Zip $x genetika $7 D051778
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a karcinom z renálních buněk $x chemie $x genetika $x sekundární $7 D002292
650    _2
$a lidské chromozomy, pár 11 $x genetika $7 D002880
650    _2
$a lidské chromozomy, pár 6 $x genetika $7 D002896
650    _2
$a diferenciální diagnóza $7 D003937
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a imunohistochemie $7 D007150
650    _2
$a hybridizace in situ fluorescenční $7 D017404
650    _2
$a nádory ledvin $x chemie $x genetika $x patologie $7 D007680
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a nádory z perivaskulárních epiteloidních buněk $x chemie $x patologie $7 D054973
650    _2
$a translokace genetická $7 D014178
655    _2
$a časopisecké články $7 D016428
700    1_
$a Brunelli, Matteo $u Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy.
700    1_
$a Segala, Diego $u Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Italy.
700    1_
$a Pedron, Serena $u Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy.
700    1_
$a Tardanico, Regina $u Department of Pathology, Spedali Civili, Brescia, Italy.
700    1_
$a Remo, Andrea $u Department of Pathology, Hospital 'Mater Salutis', Legnago, Italy.
700    1_
$a Gobbo, Stefano $u Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Italy.
700    1_
$a Meneghelli, Emanuela $u Department of Life and Reproduction Sciences, Clinical Biochemistry Laboratory, University of Verona, Verona, Italy.
700    1_
$a Doglioni, Claudio $u Department of Pathology, San Raffaele Hospital, Milano, Italy.
700    1_
$a Hes, Ondrej $u Department of Pathology, Charles University Hospital Plzen, Plzen, Czech Republic.
700    1_
$a Zampini, Claudia $u Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy.
700    1_
$a Argani, Pedram $u Department of Pathology, Johns Hopkins Medical Institutions, Baltimore, USA.
700    1_
$a Martignoni, Guido $u Department of Diagnostic and Public Health, Section of Pathology, University of Verona, Verona, Italy. Department of Pathology, Pederzoli Hospital, Peschiera del Garda, Italy.
773    0_
$w MED00003380 $t Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc $x 1530-0285 $g Roč. 31, č. 3 (2018), s. 474-487
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29052596 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20190813 $b ABA008
991    __
$a 20190823102606 $b ABA008
999    __
$a ok $b bmc $g 1433863 $s 1067174
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 31 $c 3 $d 474-487 $e 20171020 $i 1530-0285 $m Modern pathology $n Mod Pathol $x MED00003380
LZP    __
$a Pubmed-20190813

Find record

Citation metrics

Archiving options